Peter Revill

机构：The Royal Melbourne Hospital, The University of Melbourne, Victorian Infectious Diseases Reference Laboratory, Peter Doherty Institute · ORCID：0000-0003-2715-2541

发表论文 188 篇 · 总被引 5544 次 · h-index 40

代表论文

• Pathway to global elimination of hepatitis B: HBV cure is just the first step (2023 · Hepatology · 被引 48)
• HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy (2022 · EBioMedicine · 被引 30)
• CRISPR-Cas13b-mediated suppression of HBV replication and protein expression (2024 · Journal of Hepatology · 被引 26)
• Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participants (2023 · Hepatology Communications · 被引 18)
• High end‐of‐treatment hepatitis B core‐related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy (2024 · Liver International · 被引 11)
• The in vitro replication phenotype of hepatitis B virus (HBV) splice variants Sp3 and Sp9 and their impact on wild-type HBV replication (2024 · Journal of Virology · 被引 11)